Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |